Cynata Therapeutics Upholds Corporate Governance Standards

Cynata Therapeutics Limited (AU:CYP) has released an update.

Cynata Therapeutics Limited has fully complied with the ASX Corporate Governance Council’s recommendations throughout the financial year ended 30 June 2024, as detailed in their corporate governance statement. This statement, which outlines the roles and responsibilities of the board and management, is available on the company’s website. The company has been transparent with its governance practices, ensuring accountability and thorough oversight.

For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.